CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.

Difference between revisions of "User:Koichi Abe"

From CAZypedia
Jump to navigation Jump to search
m
m (Text replacement - "\^\^\^(.*)\^\^\^" to "$1")
 
Line 1: Line 1:
 
[[Image:Koichi_Abe.jpg |thumb|350 px|right]]
 
[[Image:Koichi_Abe.jpg |thumb|350 px|right]]
This is the user page of Koichi Abe. I am an applications scientist for MOLSIS Inc. (2019-). I obtained my bachelor's and master's degrees at Department of Applied Biological Science, Tokyo University of Science under the supervision of Dr. Hayao Taguchi and Dr. ^^^Masahiro Nakajima^^^. Then, I moved to Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, where I completed my Ph.D. course under the supervision of Dr. ^^^Shinya Fushinobu^^^ and Dr. Takatoshi Arakawa in 2018. Dr. ^^^Masahiro Nakajima^^^ had supported my work since I was a 4th undergraduate student. During my Ph.D. course, I contributed to structural and biochemical analysis of β-1,2-glucan-associated proteins, one of which is a [[GH144]] bacterial ''endo''-β-1,2-glucanse <cite>Abe2017</cite>. I moved to Agricultural Bioinformatics Research Unit, the University of Tokyo as a postdoctral fellow under Dr. Tohru Terada and engaged in structural analysis of various proteins using molecular simulation techniques (2018-2019). My research interests currently concerns ''in silico'' pharmacology.
+
This is the user page of Koichi Abe. I am an applications scientist for MOLSIS Inc. (2019-). I obtained my bachelor's and master's degrees at Department of Applied Biological Science, Tokyo University of Science under the supervision of Dr. Hayao Taguchi and Dr. [[User:Masahiro Nakajima|Masahiro Nakajima]]. Then, I moved to Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, where I completed my Ph.D. course under the supervision of Dr. [[User:Shinya Fushinobu|Shinya Fushinobu]] and Dr. Takatoshi Arakawa in 2018. Dr. [[User:Masahiro Nakajima|Masahiro Nakajima]] had supported my work since I was a 4th undergraduate student. During my Ph.D. course, I contributed to structural and biochemical analysis of β-1,2-glucan-associated proteins, one of which is a [[GH144]] bacterial ''endo''-β-1,2-glucanse <cite>Abe2017</cite>. I moved to Agricultural Bioinformatics Research Unit, the University of Tokyo as a postdoctral fellow under Dr. Tohru Terada and engaged in structural analysis of various proteins using molecular simulation techniques (2018-2019). My research interests currently concerns ''in silico'' pharmacology.
  
 
----
 
----

Latest revision as of 14:35, 18 December 2021

Koichi Abe.jpg

This is the user page of Koichi Abe. I am an applications scientist for MOLSIS Inc. (2019-). I obtained my bachelor's and master's degrees at Department of Applied Biological Science, Tokyo University of Science under the supervision of Dr. Hayao Taguchi and Dr. Masahiro Nakajima. Then, I moved to Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, where I completed my Ph.D. course under the supervision of Dr. Shinya Fushinobu and Dr. Takatoshi Arakawa in 2018. Dr. Masahiro Nakajima had supported my work since I was a 4th undergraduate student. During my Ph.D. course, I contributed to structural and biochemical analysis of β-1,2-glucan-associated proteins, one of which is a GH144 bacterial endo-β-1,2-glucanse [1]. I moved to Agricultural Bioinformatics Research Unit, the University of Tokyo as a postdoctral fellow under Dr. Tohru Terada and engaged in structural analysis of various proteins using molecular simulation techniques (2018-2019). My research interests currently concerns in silico pharmacology.


  1. Abe K, Nakajima M, Yamashita T, Matsunaga H, Kamisuki S, Nihira T, Takahashi Y, Sugimoto N, Miyanaga A, Nakai H, Arakawa T, Fushinobu S, and Taguchi H. (2017). Biochemical and structural analyses of a bacterial endo-β-1,2-glucanase reveal a new glycoside hydrolase family. J Biol Chem. 2017;292(18):7487-7506. DOI:10.1074/jbc.M116.762724 | PubMed ID:28270506 [Abe2017]